ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000229953.1	Ponatinib	Bladder urothelial carcinoma	0.046423576	Resistant
ENSG00000229953.1	Ponatinib	Lung squamous cell carcinoma	0.000816516	Sensitive